论文信息 - Novel intralesional rituximab regimen in recalcitrant oral pemphigus vulgaris - 字舞流文

Novel intralesional rituximab regimen in recalcitrant oral pemphigus vulgaris

Rahul Kumar | R. Kothari | Karthi Kishore | Therasal Valarmathi

[1] E. Schmidt,et al. Pemphigus , 2019, The Lancet.

[2] S. Dogra,et al. Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris. , 2015, JAMA dermatology.

[3] E. Hodak,et al. Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients. , 2013, Journal of the American Academy of Dermatology.

[4] L. Vaillant,et al. Intralesional therapy with anti‐CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B‐cell lymphoma , 2005, The British journal of dermatology.

[5] Bhushan Kumar,et al. A new grading system for oral pemphigus , 2003, International journal of dermatology.